May—Helomics Corp. (sells a drug response marker for cancer therapies) raised $34mm in a late-stage financing. According to the Form D, 45 investors participated including Bain Capital Ventures (lead) and returning backers Adams Capital Management, Quaker BioVentures, Longitude Capital, Birchmere Ventures, and TVM Capital. The money comes to Precision a year and a half after its last fundraising ($43mm in November 2008) and more than two years after failed attempts at an IPO and a merger.
Recent Financings of Private Companies (07/10)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.